Stock screenerAll disclosures →
EDGAR →
KLRS
Conviction 32HealthcareScan · Thu, Jun 25, 2026KLRS$4.32-1.93%
ResistanceSupportVol 14Insider buy5
Vol MA14 89.9K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price4.32
Change-1.93%
Gap-0.91%
Rel volume2.94×
Avg volume84.7K
Avg $ vol384.73K
SMA 204.52
SMA 505.08
SMA 2006.68
Price vs 50-15.10%
Price vs 200-35.39%
MA stackbearish
50/200 cross—
Supertrenddown · 5.19
RSI (14)41
MACD hist0.04
MACD crossbull · 6d
Stoch %K / %D38 / 44
ADX (14)15
+DI / −DI17 / 19
RSI divergence—
MACD divergence—
ATR %+7.67%
ADR %6.71%
52w high10.98
52w low2.27
From 52w high-60.70%
Above 52w low+90.09%
New 52w highNo
SqueezeOff
Bollinger width27.47%
%B0.33
Donchian pos18.85%
Donchian high5.60
Donchian low4.02
AVWAP (52w high)7.25
vs AVWAP high-40.48%
AVWAP (52w low)6.00
vs AVWAP low-28.03%
OBV trendDown
Chaikin MF (20)-0.30
Today vs 20d2.94×
Avg vol (14d)89.89K
Avg vol (20d)84.7K
Avg $ vol (20d)384.73K
Market cap102.66M
RS 3m (vs SPY)-41.29%
RS 6m (vs SPY)-59.54%
RS line new highNo
Trend template3/8
Technical rank10.2
1 week-5.16%
1 month-17.18%
3 months-29.44%
6 months-57.11%
1 year+73.29%
YTD-48.01%
P/E-2.36
P/B1.50
P/S622.20
P/FCF-2.66
EPS-2.85
Div yield—
ROE-63.36%
ROA-39.56%
Debt/Eq—
Current12.19
EV/EBITDA-1.49
Gross margin—
Net margin—
Rev growth—
EPS growth37.20%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value68.24M
Revenue165K
Net income-10.86M
Gross profit—
Free cash flow-38.57M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out23.79M
Employees20
ListedWed, Mar 19, 2025
Free float3.17M
Float %17.0%
Short interest801.52K
Days to cover10.3d
Short volume8.0%
Squeeze score80 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction32 / 100
Pattern quality—
Tech rank10.2 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.49
Support4.27
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in KLRS
No recent disclosed trades by Congress in KLRS. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in KLRS · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
AKKARAJU SRINIVAS Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 9K | $0 | 2026-06-03 | 2026-06-04 |
Ferrara Napoleone Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 9K | $0 | 2026-06-03 | 2026-06-04 |
Hallal David Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 9K | $0 | 2026-06-03 | 2026-06-04 |
ADAMIS ANTHONY P Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 9K | $0 | 2026-06-03 | 2026-06-04 |
Jovan-Embiricos Morana Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 9K | $0 | 2026-06-03 | 2026-06-04 |
PATTERSON LEONE D Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 9K | $0 | 2026-06-03 | 2026-06-04 |
Dybbs Michael Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 9K | $0 | 2026-06-03 | 2026-06-04 |
AKKARAJU SRINIVAS Director · Common Stock · 2026-05-20 | Buy | 244.3K | $1.2M | 2026-05-20 | 2026-05-22 |
AKKARAJU SRINIVAS Director · Common Stock · 2026-05-20 | Acquire | 14.94K | $0 | 2026-05-20 | 2026-05-22 |
AKKARAJU SRINIVAS Director · Common Stock · 2026-05-20 | Acquire | 4.47K | $0 | 2026-05-20 | 2026-05-22 |
SEC filings
EDGAR filings in KLRS · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.